STAT3 and hepatocellular carcinoma: Recent studies demonstrate that there is a possible crosstalk between the BMP/SMAD and the IL-6 mediated JAK/STAT3 pathway at inflammation in hepatoma cell lines and primary mouse hepatocytes [48, 49].